Clinical trials
Terminated Urogenital Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celldex Therapeutics | 3 |
| Duke University | 2 |
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Advanced Accelerator Applications | 1 |
| Alessandro D'Agnolo | 1 |
| Bioniche Life Sciences Inc. | 1 |
| Cedars-Sinai Medical Center | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| NanOlogy, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 17 |
| Neoplasms | 8 |
| Prostatic Neoplasms | 7 |
| Neoplasms by Site | 6 |
| Urinary Bladder Neoplasms | 6 |
| Genital Neoplasms, Male | 5 |
| Urologic Diseases | 5 |
| Urologic Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
| Kidney Neoplasms | 4 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.